Acetylcholine Receptors

Acetylcholine receptors are the protein targets through which acetylcholine signals across nerve, muscle, and glandular tissue, spanning fast-acting nicotinic receptors and slower muscarinic receptors. Reference standards for these targets support receptor binding assays, pharmacological screening, and structure-activity studies relevant to conditions such as myasthenia gravis and overactive bladder. Sourcing from a dedicated supplier means every compound arrives with verified identity, documented purity, and a certificate of analysis, with related analogs, impurities, and deuterated variants available from one place instead of several vendors.

Showing 1–16 of 190 results

Certified Acetylcholine Receptor Standards, Delivered With Confidence

Reliable acetylcholine receptor standards are essential wherever cholinergic signaling is being studied, whether that is early-stage drug discovery, receptor characterization, or regulatory method validation. Without a properly certified standard, results become difficult to defend or reproduce, and that risk compounds with every downstream decision built on the data, from publication to regulatory filing.

Clinivex supplies a wide range of acetylcholine receptor reference standards, each backed by a certificate of analysis and supported by our technical team for sourcing rare or hard-to-find analogs. Our catalogue covers nicotinic and muscarinic targets, related impurities, and deuterated forms, giving researchers a single point of access instead of managing several suppliers for one study.

As an ISO 9001:2015 and GMP certified supplier working with laboratories, pharmaceutical companies, and research institutions across the USA and Canada, we focus on getting the right compound to your bench quickly, with the documentation your protocols and internal quality systems require. Our team is available to advise on availability, alternatives, and lead times before you place an order.

The same cholinergic pathway also involves acetylcholinesterase, the enzyme that breaks down acetylcholine once a signal has been sent, so receptor and enzyme data are often studied together. This kind of receptor-targeted work sits within the broader field of pharmaceutical and biotech research, where cholinergic drug candidates are developed for conditions such as Alzheimer’s disease and overactive bladder. Get in touch with our team to request a quote or check availability for a specific acetylcholine receptor standard.

why Choose Clinivex?

At Clinivex, we earn trust by delivering impeccable service, expert guidance, and reliable solutions that drive long-term success. With a skilled team and customer-first approach, we stand as a leading pharmaceutical reference standards supplier in the USA and Canada.

dedicated-towards

Dedicated Towards Betterment

Driven by innovation, committed to progress.

one-stop-product

One-Stop Product Source

All-in-one destination for trusted scientific solutions.

where-trust-meet-innovation

Where Trust Meets Innovation

Blending trust, accuracy, and innovation for groundbreaking results.

fast-and-courteous

Fast and Courteous Customer Service

Merging reliability, accuracy, and innovation to redefine excellence.

Contact us

why Choose Clinivex
cta

Have questions? Get in touch!

Just fill in your details and our representatives will get back to you soon!

    Frequently Asked Questions

    Muscarinic receptor antagonists reduce involuntary bladder muscle contractions, which is the mechanism behind several medications used to treat overactive bladder.

    Myasthenia gravis often involves the immune system attacking nicotinic receptors at the neuromuscular junction, which disrupts normal signaling between nerves and muscles.

    Nicotinic receptor dysfunction is linked to myasthenia gravis, while muscarinic receptor activity is relevant to overactive bladder and some cognitive symptoms seen in neurodegenerative disease.

    Join other members of the R&D community getting the latest news, information and guides.